Fruitflow wins industry innov

RNS Number : 3072W

Provexis PLC

17 November 2010

 



17 November 2010

Provexis plc

Fruitflow wins prestigious industry innovation awards

Provexis plc ("Provexis" or the "Company"), the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, is pleased to report that Fruitflow®, the company's heart-health technology, has won two Health Ingredients Excellence Awards at the Health Ingredients Europe Conference 2010, a major trade show which is currently taking place in Madrid.
 
Fruitflow® was awarded the overall award for 'Most Innovative Health Ingredient' at the conference and in addition won best innovation in the 'Heart Health' category.

Fruitflow® helps maintain a healthy cardiovascular system by keeping platelets smooth and reducing platelet aggregation. In December 2009 it was the first product to receive a health claim under Article 13(5) from the European Food Safety Authority. In June 2010 Provexis entered into a long term Alliance Agreement with DSM Nutrition, the global ingredients supplier, who will market and distribute Fruitflow®.

Provexis CEO Stephen Moon said "We are delighted to receive these two highly respected awards, which endorse further the innovation which our scientifically-proven Fruitflow technology brings to the substantial and growing market for cardiovascular functional foods and dietary supplements. The Health Ingredients Europe Conference marks the formal launch of Fruitflow by our alliance partner DSM and we look forward to working alongside them in commercialising our lead product."

-ends-

For further information please contact:

Stephen Moon, Chief Executive

Provexis plc                                                      Tel:       [phone]

Bobbie Hilliam                                                  Tel:       [phone]

Evolution Securities

Haggie Financial LLP:                                   Tel:     [phone]

Matthew Longbottom/Peter Rigby               [e-mail]

 

END

 

 

MSCFFWEFMFSSESF